NREP
NEW REPRESENTATIVE AT IB RECEIVED
04/07/2025
Voltar para busca
Dado oficial do USPTO
THERAPANACEA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
THERAPANACEA
ST13
US500000079281530Classe
9, 38, 42, 44
Pedido
79281530
Registro
6624153
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
43
Atualização mais recente
05/07/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
9, 38, 42, 44
Data de depósito
26/11/2019
Data de registro
25/01/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
25/01/2022
Última transação
05/07/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
FR
Examinador
VALLILLO, MELISSA
Unidade examinadora
L50
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
THERAPANACEA
Representantes
Jess M. Collen Collen IP Intellectual Property Law, P.C.
Classificação técnica
Classes Nice
Classe 9Classe 38Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 9
image recording apparatus; image transmission apparatus; image reproduction apparatus; digital recording mediavideo recorders; diagnostic apparatus not for medical useapparatus for the detection of pathogens for laboratory or research use; downloadable software for use in the field of cancer therapy and pathogen detection; recorded software for use in determining treatment protocols in the field of cancer therapy; downloadable artificial intelligence software in particular for use in determining treatment protocols in relation to precision radiotherapy treatment of cancer; downloadable software applications for use in medical data analysis; downloadable software platforms for use in analysis of medical outcomes; recorded or downloadable embedded operating software for X-ray CT scanners; downloadable tablet computer software and software applications for use in medical data analysis; recorded virtual reality software for use in guiding surgical instruments during surgery; data storage devices for use in the field of cancer management; teaching apparatus and simulatorselectronic clinicians training simulators
Classe 38
provision of access to databases; transmission of medical digital files; transmission of digital files for use in the receptioncare and accompaniment of sick persons and of patients through computer applications and dynamic display screensa website accessible online particularly via a tabletmobile telephone or computervia a social network and via interactive orientation terminals; all the foregoing in the field of cancer research and cancer treatment
Classe 42
Scientific and medical research; research and development of new therapies for cancer treatment; scientific research in the medical fieldin particular relating to cancer treatment; software design using artificial intelligence in the field of cancer treatment aimed at developing precision radiation therapy for improving the clinical effects of treatment; computer system analysis; computer system design; computer hardware design and development services provided by consultants; digitization of documents; software as a service (SaaS) services featuring software for use in analyzing medical research data; cloud computing featuring software for use in scientific data management; information technology (IT) consultancy; server hosting; electronic data storage; all the foregoing in the medical fieldin particular for cancer treatment
Classe 44
medical analysis servicesmedical diagnostic testing services; Provision of health care and medical services by health care professionals via the Internet or telecommunication networks; laboratory services relating to treatment of personsmedical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical imagingradiotherapybrachytherapy and medical dosimetry services for the treatment of cancer; information in the field of cancer treatment; medical services for cancer treatment; medical analysis services for cancer diagnosis; providing cancer screening services; information in the fields of healthcancer and cancer treatmentrecovery and survival via a global computer network; medical evaluation and medical diagnosis of cancer; prognosis evaluation in cancer therapy
Publicações
Histórico de despachos e eventos da marca no USPTO.
43 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
29/10/2022
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
18/07/2022
FICS
FINAL DISPOSITION NOTICE SENT TO IB
29/06/2022
FIMP
FINAL DISPOSITION PROCESSED
29/06/2022
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
25/04/2022
NREP
NEW REPRESENTATIVE AT IB RECEIVED
19/03/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
25/01/2022
GPNX
NOTIFICATION PROCESSED BY IB
15/11/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
09/11/2021
PUBO
PUBLISHED FOR OPPOSITION
09/11/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
20/10/2021
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
20/10/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
20/10/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/10/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
24/09/2021
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
10/09/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
30/08/2021
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
25/08/2021
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25/08/2021
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
02/08/2021
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
22/10/2020
GNSL
LETTER OF SUSPENSION E-MAILED
22/10/2020
CNSL
SUSPENSION LETTER WRITTEN
22/10/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/10/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/10/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
08/10/2020
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
08/10/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/10/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/10/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/10/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/10/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/10/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
07/10/2020
RFNT
REFUSAL PROCESSED BY IB
01/05/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
16/04/2020
RFRR
REFUSAL PROCESSED BY MPU
15/04/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
28/03/2020
CNRT
NON-FINAL ACTION WRITTEN
27/03/2020
MAFR
APPLICATION FILING RECEIPT MAILED
27/03/2020
DOCK
ASSIGNED TO EXAMINER
23/03/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/03/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
19/03/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace THERAPANACEA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.